Oncotelic Therapeutics, Inc. ( OTLC) - Stock Earnings
OTLC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 18, 2026, midnight | — / — | — | — / — | — |
OTLC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -525419 USD | — USD |
| 2023Q2 | -6.8 million USD | — USD |
| 2023Q3 | — USD | 70000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OTLC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | — USD | 1.7 million USD |
| 2021 | -9.4 million USD | — USD |
| 2022 | 5.1 million USD | — USD |
OTLC
Price: $0.02
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -4
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9.6 million